The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

A correction to this article has been published: Okoye et al., J. Exp. Med. 204 (10) 2493
Published online
doi:10.1084/jem.20070567
The Journal of Experimental Medicine, Vol. 204, No. 9, 2171-2185
The Rockefeller University Press, 0022-1007 $30.00
© Okoye et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 5843K)
Right arrow PPT slides of all figures
Right arrow Correction (v204,p2493)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okoye, A.
Right arrow Articles by Picker, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okoye, A.
Right arrow Articles by Picker, L. J.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Progressive CD4+ central–memory T cell decline results in CD4+ effector–memory insufficiency and overt disease in chronic SIV infection

Afam Okoye1, Martin Meier-Schellersheim2, Jason M. Brenchley3, Shoko I. Hagen1, Joshua M. Walker1, Mukta Rohankhedkar1, Richard Lum1, John B. Edgar1, Shannon L. Planer1, Alfred Legasse1, Andrew W. Sylwester1, Michael Piatak, Jr.4, Jeffrey D. Lifson4, Vernon C. Maino5, Donald L. Sodora6, Daniel C. Douek3, Michael K. Axthelm1, Zvi Grossman2,7, and Louis J. Picker1

1 Vaccine and Gene Therapy Institute, Department of Pathology, and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
2 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892
3 Human Immunology Section, Vaccine Research Center, Bethesda, MD 20892
4 AIDS Vaccine Program, Science Applications International Corporation (SAIC) Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702
5 Becton Dickinson Biosciences, San Jose, CA 95131
6 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390
7 Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel

CORRESPONDENCE Louis J. Picker: pickerl{at}ohsu.edu

Primary simian immunodeficiency virus (SIV) infections of rhesus macaques result in the dramatic depletion of CD4+ CCR5+ effector–memory T (TEM) cells from extra-lymphoid effector sites, but in most infections, an increased rate of CD4+ memory T cell proliferation appears to prevent collapse of effector site CD4+ TEM cell populations and acute-phase AIDS. Eventually, persistent SIV replication results in chronic-phase AIDS, but the responsible mechanisms remain controversial. Here, we demonstrate that in the chronic phase of progressive SIV infection, effector site CD4+ TEM cell populations manifest a slow, continuous decline, and that the degree of this depletion remains a highly significant correlate of late-onset AIDS. We further show that due to persistent immune activation, effector site CD4+ TEM cells are predominantly short-lived, and that their homeostasis is strikingly dependent on the production of new CD4+ TEM cells from central–memory T (TCM) cell precursors. The instability of effector site CD4+ TEM cell populations over time was not explained by increasing destruction of these cells, but rather was attributable to progressive reduction in their production, secondary to decreasing numbers of CCR5 CD4+ TCM cells. These data suggest that although CD4+ TEM cell depletion is a proximate mechanism of immunodeficiency, the tempo of this depletion and the timing of disease onset are largely determined by destruction, failing production, and gradual decline of CD4+ TCM cells.


Abbreviations used: ART, antiretroviral therapy; BAL, bronchoalveolar lavage; PID, postinfection day; PLN, peripheral LN; pvl, plasma viral load; RM, rhesus macaque; SHIV, simian immunodeficiency virus/HIV hybrid virus; SIV, simian immunodeficiency virus; TCM, central–memory T; TEM, effector–memory T.

The Rockefeller University Press


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Precursor loss triggers AIDS
Hema Bashyam
J. Exp. Med. 2007 204: 2010. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS